{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:46:34Z","timestamp":1780490794543,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014387","name":"Acadia Pharmaceuticals Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014387","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020265","name":"Stan Perron Charitable Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100020265","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurodevelop Disord"],"DOI":"10.1186\/s11689-025-09669-7","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:36:55Z","timestamp":1767778615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Longitudinal Rett syndrome behaviour questionnaire scores and their associations with genotype and trajectories of mobility, weight and seizure frequency status"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7358-9037","authenticated-orcid":false,"given":"Jenny","family":"Downs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5178-6080","authenticated-orcid":false,"given":"Kingsley","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0970-2158","authenticated-orcid":false,"given":"Dilesh","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6405-5834","authenticated-orcid":false,"given":"Helen","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"9669_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1203\/PDR.0b013e3182242461","volume":"70","author":"S Fehr","year":"2011","unstructured":"Fehr S, Bebbington A, Nassar N, Downs J, Ronen GM, de Klerk N, Leonard H. Trends in the diagnosis of Rett syndrome in Australia. Pediatr Res. 2011;70:313\u20139.","journal-title":"Pediatr Res"},{"key":"9669_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","volume":"23","author":"RE Amir","year":"1999","unstructured":"Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23:185\u20138.","journal-title":"Nat Genet"},{"key":"9669_CR3","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ana.22124","volume":"68","author":"J Neul","year":"2010","unstructured":"Neul J, Kaufmann W, Glaze D, Christodoulou J, Clarke A, Bahi-Buisson N, Leonard H, Bailey M, Schanen N, Zappella M, Renieri A, Huppke P, Percy AK. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol. 2010;68:944\u201350.","journal-title":"Ann Neurol"},{"key":"9669_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrneurol.2016.186","volume":"13","author":"H Leonard","year":"2017","unstructured":"Leonard H, Cobb S, Downs J. Clinical and biological progress over 50 years in Rett syndrome. Nat Reviews Neurol. 2017;13:37\u201351.","journal-title":"Nat Reviews Neurol"},{"key":"9669_CR5","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/1469-7610.00236","volume":"43","author":"RH Mount","year":"2002","unstructured":"Mount RH, Charman T, Hastings RP, Reilly S, Cass H. The Rett syndrome behaviour questionnaire (RSBQ): refining the behavioural phenotype of Rett syndrome. J Child Psychol Psychiatry. 2002;43:1099\u2013110.","journal-title":"J Child Psychol Psychiatry"},{"key":"9669_CR6","unstructured":"Kaur S, Christodoulou J. MECP2 Disorders. In: Adam MP, Feldman J, Mirzaa GM editors. GeneReviews\u00ae. Seattle (WA): University of Washington; 2001 [Updated 2019 Sep 19]."},{"key":"9669_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.pediatrneurol.2020.01.009","volume":"107","author":"W Hou","year":"2020","unstructured":"Hou W, Bhattacharya U, Pradana WA, Tarquinio DC. Assessment of a clinical trial metric for Rett syndrome: critical analysis of the Rett syndrome behavioural questionnaire. Pediatr Neurol. 2020;107:48\u201356.","journal-title":"Pediatr Neurol"},{"key":"9669_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1352\/1944-7558-128.3.237","volume":"128","author":"LM Oberman","year":"2023","unstructured":"Oberman LM, Leonard H, Downs J, Cianfaglione R, Stahlhut M, Larsen JL, Madden KV, Kaufmann WE. Rett syndrome behaviour questionnaire in children and adults with Rett syndrome: psychometric characterization and revised factor structure. Am J Intellect Dev Disabil. 2023;128:237\u201353.","journal-title":"Am J Intellect Dev Disabil"},{"key":"9669_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s11689-015-9127-4","volume":"7","author":"KV Barnes","year":"2015","unstructured":"Barnes KV, Coughlin FR, O\u2019Leary HM, Bruck N, Bazin GA, Beinecke EB, Walco AC, Cantwell NG, Kaufmann WE. Anxiety-like behavior in Rett syndrome: characteristics and assessment by anxiety scales. J Neurodevelopmental Disorders. 2015;7:30.","journal-title":"J Neurodevelopmental Disorders"},{"key":"9669_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ajmg.b.30270","volume":"141","author":"L Robertson","year":"2006","unstructured":"Robertson L, Hall S, Jacoby P, Ellaway C, de Klerk N, Leonard H. The association between behaviour and genotype in Rett syndrome using the Australian Rett syndrome database. Am J Med Genet Part B Neuropsychiatric Genet. 2006;141:177\u201383.","journal-title":"Am J Med Genet Part B Neuropsychiatric Genet"},{"key":"9669_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/jir.12228","volume":"60","author":"R Cianfaglione","year":"2016","unstructured":"Cianfaglione R, Clarke A, Kerr M, Hastings RA-O, Oliver C, Felce D. Ageing in Rett syndrome. J Intellect Disabil Res. 2016;60:182\u201390.","journal-title":"J Intellect Disabil Res"},{"key":"9669_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s11689-024-09575-4","volume":"16","author":"J Downs","year":"2024","unstructured":"Downs J, Wong K, Leonard H. Associations between genotype, phenotype and behaviours measured by the Rett syndrome behaviour questionnaire in Rett syndrome. J Neurodevelopmental Disorders. 2024;16:59.","journal-title":"J Neurodevelopmental Disorders"},{"key":"9669_CR13","doi-asserted-by":"publisher","first-page":"106704","DOI":"10.1016\/j.cct.2022.106704","volume":"114","author":"JL Neul","year":"2022","unstructured":"Neul JL, Percy AK, Benke TA, Berry-Kravis EM, Glaze DG, Peters SU, Jones NE, Youakim JM. Design and outcome measures of LAVENDER, a phase 3 study of Trofinetide for Rett syndrome. Contemp Clin Trials. 2022;114:106704.","journal-title":"Contemp Clin Trials"},{"key":"9669_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/acn3.533","volume":"5","author":"HM O\u2019Leary","year":"2018","unstructured":"O\u2019Leary HM, Kaufmann WE, Barnes KV, Rakesh K, Kapur K, Tarquinio DC, Cantwell NG, Roche KJ, Rose SA, Walco AC, Bruck NS, Bazin GA, Holm IA, Alexander ME, Swanson LC, Torres JMM, Nelson CA III, Sahin M. Placebo controlled crossover efficacy assessment of Mecasermin for the treatment of Rett syndrome. Ann Clin Transl Neurol. 2018;5:323\u201332.","journal-title":"Ann Clin Transl Neurol"},{"key":"9669_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pediatrneurol.2017.07.002","volume":"76","author":"DG Glaze","year":"2017","unstructured":"Glaze DG, Neul JL, Percy A, Feyma T, Beisang A, Yaroshinsky A, Stoms G, Zuchero D, Horrigan J, Glass L, Jones NE. A Double-Blind, Randomized, Placebo-Controlled clinical study of Trofinetide in the treatment of Rett syndrome. Pediatr Neurol. 2017;76:37\u201346.","journal-title":"Pediatr Neurol"},{"key":"9669_CR16","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41591-023-02398-1","volume":"29","author":"JL Neul","year":"2023","unstructured":"Neul JL, Percy AK, Benke TA, Berry-Kravis E, Glaze M, Marsh DG, Lin ED, Stankovic T, Bishop S, Youakim KM. Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study. Nat Med. 2023;29:1468\u201375.","journal-title":"Nat Med"},{"key":"9669_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrneurol.2016.186","volume":"13","author":"H Leonard","year":"2016","unstructured":"Leonard H, Cobb S, Downs J. Clinical and biological progress over 50 years in Rett syndrome. Nat Reviews Neurol. 2016;13:37\u201351.","journal-title":"Nat Reviews Neurol"},{"key":"9669_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jmedgenet-2013-102113","volume":"51","author":"V Cuddapah","year":"2014","unstructured":"Cuddapah V, Pillai R, Shekar K, Lane J, Motil K, Skinner S, Tarquinio D, Glaze D, McGwin G, Kaufmann W, Percy A, Neul J, Olsen M. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome. J Med Genet. 2014;51:152\u20138.","journal-title":"J Med Genet"},{"issue":"Suppl 1","key":"9669_CR19","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/S0387-7604(01)00346-1","volume":"23","author":"CJ Ellaway","year":"2001","unstructured":"Ellaway CJ, Peat J, Williams K, Leonard H, Christodoulou J. Medium-term open label trial of L-carnitine in Rett syndrome. Brain Dev. 2001;23(Suppl 1):S85\u20139.","journal-title":"Brain Dev"},{"key":"9669_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1542\/peds.109.1.45","volume":"109","author":"CL Ogden","year":"2002","unstructured":"Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL. Centers for disease control and prevention 2000 growth charts for the united states: improvements to the 1977 National center for health statistics version. Pediatrics. 2002;109:45\u201360.","journal-title":"Pediatrics"},{"key":"9669_CR21","doi-asserted-by":"publisher","first-page":"100323","DOI":"10.1016\/j.alcr.2019.100323","volume":"43","author":"G van der Nest","year":"2020","unstructured":"van der Nest G, Lima Passos V, Candel M, van Breukelen GJP. An overview of mixture modelling for latent evolutions in longitudinal data: modelling approaches, fit statistics and software. Adv Life Course Res. 2020;43:100323.","journal-title":"Adv Life Course Res"},{"key":"9669_CR22","doi-asserted-by":"publisher","first-page":"e0147555","DOI":"10.1371\/journal.pone.0147555","volume":"11","author":"J Downs","year":"2016","unstructured":"Downs J, Stahlhut M, Wong K, Syhler B, Bisgaard AM, Jacoby P, Leonard H. Validating the Rett syndrome gross motor scale. PLoS ONE. 2016;11:e0147555.","journal-title":"PLoS ONE"},{"key":"9669_CR23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/dmcn.12093","volume":"55","author":"X Bao","year":"2013","unstructured":"Bao X, Downs J, Wong K, Williams S, Leonard H. Using a large international sample to investigate epilepsy in Rett syndrome. Dev Med Child Neurol. 2013;55:553\u20138.","journal-title":"Dev Med Child Neurol"},{"key":"9669_CR24","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.medj.2024.05.018","volume":"5","author":"AK Percy","year":"2024","unstructured":"Percy AK, Neul JL, Benke TA, Berry-Kravis EM, Glaze DG, Marsh ED, An D, Bishop KM, Youakim JM. Trofinetide for the treatment of Rett syndrome: results from the open-label extension LILAC study. Med. 2024;5:1178\u2013e893.","journal-title":"Med"},{"key":"9669_CR25","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.medj.2024.06.007","volume":"5","author":"AK Percy","year":"2024","unstructured":"Percy AK, Neul JL, Benke TA, Berry-Kravis EM, Glaze DG, Marsh ED, Barrett AM, An D, Bishop KM, Youakim JM. Trofinetide for the treatment of Rett syndrome: Long-term safety and efficacy results of the 32-month, open-label LILAC-2 study. Med. 2024;5:1275\u2013e812.","journal-title":"Med"},{"key":"9669_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jsr.12240","volume":"24","author":"K Wong","year":"2015","unstructured":"Wong K, Leonard H, Jacoby P, Ellaway C, Downs J. The trajectories of sleep disturbances in Rett syndrome. J Sleep Res. 2015;24:223\u201333.","journal-title":"J Sleep Res"},{"key":"9669_CR27","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1136\/jmg-2022-108905","volume":"60","author":"C Kay","year":"2023","unstructured":"Kay C, Leonard H, Smith J, Wong K, Downs J. Genotype and sleep independently predict mental health in Rett syndrome: an observational study. J Med Genet. 2023;60:951\u20139.","journal-title":"J Med Genet"},{"key":"9669_CR28","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1097\/BRS.0000000000001399","volume":"41","author":"J Downs","year":"2016","unstructured":"Downs J, Torode I, Wong K, Ellaway C, Elliott EJ, Christodoulou J, Jacoby P, Thomson MR, Izatt MT, Askin GN, McPhee BI, Bridge C, Cundy P, Leonard H. The natural history of scoliosis in females with Rett syndrome. Spine (Phila Pa 1976). 2016;41:856\u201363.","journal-title":"Spine (Phila Pa 1976)"},{"key":"9669_CR29","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1002\/ajmg.a.62429","volume":"185","author":"AM Bisgaard","year":"2021","unstructured":"Bisgaard AM, Wong K, H\u00f8jfeldt AK, Larsen JL, Sch\u00f6newolf-Greulich B, R\u00f8nde G, Downs J, Stahlhut M. Decline in gross motor skills in adult Rett syndrome; results from a Danish longitudinal study. Am J Med Genet A. 2021;185:3683\u201393.","journal-title":"Am J Med Genet A"},{"key":"9669_CR30","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1469-8749.2010.03636.x","volume":"52","author":"J Downs","year":"2010","unstructured":"Downs J, Bebbington A, Jacoby P, Williams AM, Ghosh S, Kaufmann WE, Leonard H. Level of purposeful hand function as a marker of clinical severity in Rett syndrome. Dev Med Child Neurol. 2010;52:817\u201323.","journal-title":"Dev Med Child Neurol"},{"key":"9669_CR31","doi-asserted-by":"crossref","unstructured":"Downs J, Wong K, Drummond C, Leonard H. Longitudinal evaluation of the stability of hand function in Rett syndrome. J Pediatr. 2021;237:244-249.","DOI":"10.1016\/j.jpeds.2021.06.060"},{"key":"9669_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/cns3.20038","volume":"1","author":"JL Neul","year":"2023","unstructured":"Neul JL, Benke TA, Marsh ED, Lane JB, Lieberman DN, Skinner SA, Glaze DG, Suter B, Heydemann PT, Beisang AA, Standridge SM, Ryther RCC, Haas RH, Edwards LJ, Ananth A, Percy AK. Distribution of hand function by age in individuals with Rett syndrome. Ann Child Neurol Soc. 2023;1:228\u201338.","journal-title":"Ann Child Neurol Soc"},{"key":"9669_CR33","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1212\/WNL.0b013e31826e9a70","volume":"79","author":"DC Tarquinio","year":"2012","unstructured":"Tarquinio DC, Motil KJ, Hou W, Lee HS, Glaze DG, Skinner SA, Neul JL, Annese F, McNair L, Barrish JO, Geerts SP, Lane JB, Percy AK. Growth failure and outcome in Rett syndrome: specific growth references. Neurology. 2012;79:1653\u201361.","journal-title":"Neurology"},{"key":"9669_CR34","doi-asserted-by":"crossref","unstructured":"Wong K, Downs J, Ellaway C, Baikie G, Ravikumara M, Jacoby P, Christodoulou J, Elliott EJ, Leonard H. Impact of gastrostomy placement on nutritional Status, physical Health, and parental Well-Being of females with Rett syndrome: A longitudinal study of an Australian population. J Pediatr. 2018; 200: 188\u2009-\u200995.e1.","DOI":"10.1016\/j.jpeds.2018.04.050"},{"key":"9669_CR35","doi-asserted-by":"publisher","first-page":"e000717","DOI":"10.1136\/bmjpo-2020-000717","volume":"4","author":"C Fu","year":"2020","unstructured":"Fu C, Armstrong D, Marsh E, Lieberman D, Motil K, Witt R, Standridge S, Nues P, Lane J, Dinkel T, Coenraads M, von Hehn J, Jones M, Hale K, Suter B, Glaze D, Neul J, Percy A, Benke T. Consensus guidelines on managing Rett syndrome across the lifespan. BMJ Paediatr Open. 2020;4:e000717.","journal-title":"BMJ Paediatr Open"},{"key":"9669_CR36","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/sj.ejhg.5201479","volume":"13","author":"L Jian","year":"2005","unstructured":"Jian L, Archer HL, Ravine D, Kerr A, de Klerk N, Christodoulou J. p.R270X MECP2 mutation and mortality in Rett syndrome. Eur J Hum Genet. 2005;13:1235\u20138.","journal-title":"Eur J Hum Genet"},{"key":"9669_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1750-1172-9-87","volume":"9","author":"A Anderson","year":"2014","unstructured":"Anderson A, Wong K, Jacoby P, Downs J, Leonard H. Twenty years of surveillance in Rett syndrome: what does this tell us? Orphanet J Rare Dis. 2014;9:87.","journal-title":"Orphanet J Rare Dis"},{"key":"9669_CR38","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.pediatrneurol.2015.06.003","volume":"53","author":"DC Tarquinio","year":"2015","unstructured":"Tarquinio DC, Hou W, Neul JL, Kaufmann WE, Glaze DG, Motil KJ, Skinner SA, Lee HS, Percy AK. The changing face of survival in Rett syndrome and MECP2-Related disorders. Pediatr Neurol. 2015;53:402\u201311.","journal-title":"Pediatr Neurol"}],"container-title":["Journal of Neurodevelopmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11689-025-09669-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-025-09669-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-025-09669-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T11:28:30Z","timestamp":1770204510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11689-025-09669-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9669"],"URL":"https:\/\/doi.org\/10.1186\/s11689-025-09669-7","relation":{},"ISSN":["1866-1955"],"issn-type":[{"value":"1866-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Child and Adolescent Health Services Human Research Ethics Committee approved the AussieRett study (RGS2390). Primary caregivers provided informed written consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"JD: Consultancy for Marinus, Ultragenyx, Acadia, Avexis, Orion, Neurogene and Taysha; Clinical Trials with Anavex and Newron; All consultancies are unrelated to this work and all remuneration has been made to her department.HL: Consultancy for Marinus, Acadia, Avexis and Orion; Clinical Trials with Anavex and Newron; All remuneration has been made to her department. All consultancies are unrelated to this work.DD: Employee at Acadia Pharmaceuticals. KW: Has no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}